Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Objective Nutrients is a UK-based nutraceutical company specializing in high-quality, excipient-free nutritional supplements, with a primary focus on thiamine derivatives. Founded by nutritionist Elliot Overton and Carl Daley, the company is best known for its flagship product, Thiamax, which utilizes the thiamine derivative thiamine tetrahydrofurfuryl disulfide (TTFD) to support neurological and metabolic health. The company's mission is to provide pure, unadulterated formulations without artificial fillers or additives, catering to individuals with sensitivities and those seeking clinical-grade nutritional support. Objective Nutrients also offers a range of products targeting gut health, liver function, and antioxidant status, positioning itself as a leader in the application of high-dose thiamine therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Objective Nutrition.